Free Trial

Traders Purchase Large Volume of Call Options on Albemarle (NYSE:ALB)

Albemarle logo with Basic Materials background

Key Points

  • Albemarle Corporation experienced a significant surge in options trading, with 54,662 call options purchased, marking a 206% increase over its average daily volume.
  • Equities analysts have issued mixed ratings on Albemarle, with six analysts rating it as a sell and a consensus average price target of $88.06.
  • The company reported a negative net margin of 18.61% in its latest earnings, but surpassed analysts' EPS expectations by reporting $0.11 earnings per share.
  • Looking to export and analyze Albemarle data? Unlock 5 Weeks of MarketBeat All Access for Just $5. Claim Your Limited-Time Discount.

Albemarle Corporation (NYSE:ALB - Get Free Report) saw unusually large options trading activity on Wednesday. Stock traders bought 54,662 call options on the company. Thisrepresentsanincreaseof206% compared to the average daily volume of 17,860 call options.

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on the stock. Piper Sandler set a $68.00 target price on shares of Albemarle and gave the company an "underweight" rating in a research note on Wednesday, May 14th. Wells Fargo & Company decreased their target price on shares of Albemarle from $75.00 to $70.00 and set an "equal weight" rating for the company in a research note on Friday, August 1st. KeyCorp reiterated a "sector weight" rating on shares of Albemarle in a research note on Wednesday, July 30th. Robert W. Baird reiterated an "underperform" rating and issued a $60.00 target price on shares of Albemarle in a research note on Tuesday, July 29th. Finally, TD Securities decreased their target price on shares of Albemarle from $115.00 to $65.00 and set a "hold" rating for the company in a research note on Thursday, May 1st. Six equities research analysts have rated the stock with a sell rating, nine have issued a hold rating and three have assigned a buy rating to the company's stock. According to data from MarketBeat, the company currently has a consensus rating of "Hold" and an average price target of $88.06.

View Our Latest Analysis on ALB

Albemarle Price Performance

Shares of Albemarle stock traded up $1.78 during trading hours on Wednesday, reaching $79.76. 1,958,022 shares of the company's stock were exchanged, compared to its average volume of 3,552,845. Albemarle has a 1 year low of $49.43 and a 1 year high of $113.91. The company has a market capitalization of $9.39 billion, a P/E ratio of -8.56 and a beta of 1.63. The business has a fifty day moving average of $68.18 and a two-hundred day moving average of $68.06. The company has a quick ratio of 1.47, a current ratio of 2.31 and a debt-to-equity ratio of 0.38.

Albemarle (NYSE:ALB - Get Free Report) last released its earnings results on Wednesday, July 30th. The specialty chemicals company reported $0.11 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.83) by $0.94. Albemarle had a negative net margin of 18.61% and a negative return on equity of 1.87%. The business had revenue of $1.33 billion during the quarter, compared to analyst estimates of $1.23 billion. During the same quarter in the prior year, the firm earned $0.04 earnings per share. The company's revenue for the quarter was down 7.0% compared to the same quarter last year. As a group, research analysts predict that Albemarle will post -0.04 earnings per share for the current fiscal year.

Albemarle Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 1st. Investors of record on Friday, September 12th will be issued a $0.405 dividend. The ex-dividend date of this dividend is Friday, September 12th. This represents a $1.62 dividend on an annualized basis and a dividend yield of 2.0%. Albemarle's dividend payout ratio is currently -17.38%.

Institutional Investors Weigh In On Albemarle

A number of hedge funds have recently modified their holdings of ALB. Envestnet Asset Management Inc. grew its holdings in shares of Albemarle by 9.7% in the fourth quarter. Envestnet Asset Management Inc. now owns 177,939 shares of the specialty chemicals company's stock valued at $15,317,000 after purchasing an additional 15,778 shares during the period. Renaissance Technologies LLC lifted its position in Albemarle by 2,151.9% in the fourth quarter. Renaissance Technologies LLC now owns 60,800 shares of the specialty chemicals company's stock valued at $5,234,000 after buying an additional 58,100 shares during the last quarter. Advisory Services Network LLC lifted its position in Albemarle by 4.8% in the fourth quarter. Advisory Services Network LLC now owns 8,380 shares of the specialty chemicals company's stock valued at $721,000 after buying an additional 387 shares during the last quarter. Treasurer of the State of North Carolina lifted its position in Albemarle by 0.6% in the fourth quarter. Treasurer of the State of North Carolina now owns 51,580 shares of the specialty chemicals company's stock valued at $4,440,000 after buying an additional 320 shares during the last quarter. Finally, Sterling Capital Management LLC lifted its position in Albemarle by 55.4% in the fourth quarter. Sterling Capital Management LLC now owns 6,953 shares of the specialty chemicals company's stock valued at $599,000 after buying an additional 2,480 shares during the last quarter. Hedge funds and other institutional investors own 92.87% of the company's stock.

Albemarle Company Profile

(Get Free Report)

Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Energy Storage, Specialties and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services.

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Albemarle Right Now?

Before you consider Albemarle, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Albemarle wasn't on the list.

While Albemarle currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

September Slowdown: 3 Stocks to Buy When the Pullback Comes
3 Overlooked Stocks Riding the AI Data Center Boom
3 Growth Stock Winners to Watch And 3 to Avoid

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines